Park Medi World Share Price Today Rises After Q2 Results; Net Profit Falls 30%, Revenue Hits Record High

Park Medi World Ltd shares ended marginally higher on Friday, November 13, after the hospital chain operator announced its September-quarter results for FY27. The stock remained in focus as the company reported record quarterly revenue, supported by higher patient volumes, even as declining net profit and a sharp contraction in operating margins highlighted near-term cost pressures.

The healthcare stock's performance came as investors assessed the contrasting signals from the results, with business growth remaining strong but profitability taking a hit amid capacity expansion and higher operating expenses.

Park Medi World Share Price Today

Park Medi World shares closed at Rs 255 on Friday, November 13, up 0.29% on the NSE. The stock opened at Rs 257.40 and touched an intraday high of Rs 260.90 before falling to a low of Rs 232 during the trading session.

The stock's movement followed the company's latest quarterly earnings announcement, which showed that revenue growth had not translated into higher profits. While patient numbers reached a record level, increased costs and the ramp-up of newly added hospital beds weighed on the company's operating performance.

Park Medi World Q2 Results Highlights: Net Profit Falls Nearly 30%

Park Medi World reported consolidated net profit of around Rs 52 crore in Q2 FY27, down 29.7% from Rs 74 crore in the corresponding quarter last year. The decline in earnings came despite a strong increase in revenue from operations.

Revenue from operations reached a record Rs 511 crore, rising 24.6% year-on-year from Rs 410 crore in Q2 FY26. Revenue also grew around 7% sequentially from Rs 475.7 crore in the June quarter, reflecting continued growth in the company's business.

However, higher operating expenses limited the benefit of the revenue increase. The results highlighted the challenge of maintaining profitability while expanding hospital capacity and managing the costs associated with new facilities.

Park Medi World Q2 EBITDA Falls 9.5%; Margins Come Under Pressure

Park Medi World's EBITDA declined approximately 9.5% year-on-year to Rs 101.8 crore from Rs 112.5 crore in the year-ago quarter. Higher material costs and employee expenses contributed to the decline in operating earnings.

The EBITDA margin contracted to around 20% from 27.4% in Q2 FY26, a reduction of approximately 740 basis points. The sharp decline in margins indicates that the company's expenses increased faster than its revenue, putting pressure on operating profitability.

For hospital operators, newly added beds and facilities can increase costs before occupancy reaches sustainable levels. The pace at which these facilities begin contributing to revenue and earnings will therefore remain important for Park Medi World's financial performance.

Despite the decline in profit, Park Medi World treated approximately 2.90 lakh patients during the quarter, its highest-ever patient count for a three-month period. The record volume indicates continued demand for its healthcare services.

Chairman Ajit Gupta and Managing Director Ankit Gupta said the company added 680 beds over six months through its Rudrapur and Panchkula facilities, taking its total capacity to 4,290 beds. The management noted that the additions affected occupancy and profitability in the near term, as new facilities require time to scale up.

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.